Related references
Note: Only part of the references are listed.Physiological predictors of survival in patients with sarcoidosis-associated pulmonary hypertension: results from an international registry
Oksana A. Shlobin et al.
EUROPEAN RESPIRATORY JOURNAL (2020)
Clinical phenotypes and outcomes of precapillary pulmonary hypertension of sickle cell disease
Laurent Savale et al.
EUROPEAN RESPIRATORY JOURNAL (2019)
Haemodynamic definitions and updated clinical classification of pulmonary hypertension
Gerald Simonneau et al.
EUROPEAN RESPIRATORY JOURNAL (2019)
2019 sickle cell disease guidelines by the American Society of Hematology: methodology, challenges, and innovations
M. Hassan Murad et al.
BLOOD ADVANCES (2019)
Increased incidence of VTE in sickle cell disease patients: risk factors, recurrence and impact on mortality
Ann Brunson et al.
BRITISH JOURNAL OF HAEMATOLOGY (2017)
Chronic Pulmonary Complications of Sickle Cell Disease
Alem Mehari et al.
CHEST (2016)
Cardiomyopathy With Restrictive Physiology in Sickle Cell Disease
Omar Niss et al.
JACC-CARDIOVASCULAR IMAGING (2016)
Vasculopathy and pulmonary hypertension in sickle cell disease
Karin P. Potoka et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2015)
An Official American Thoracic Society Clinical Practice Guideline: Diagnosis, Risk Stratification, and Management of Pulmonary Hypertension of Sickle Cell Disease
Elizabeth S. Klings et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2014)
Hemodynamic Predictors of Mortality in Adults with Sickle Cell Disease
Alem Mehari et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2013)
Pulmonary Complications of Sickle Cell Disease
Andrew C. Miller et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2012)
Mortality in Adults With Sickle Cell Disease and Pulmonary Hypertension
Alem Mehari et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2012)
Hospitalization for pain in patients with sickle cell disease treated with sildenafil for elevated TRV and low exercise capacity
Roberto F. Machado et al.
BLOOD (2011)
A Hemodynamic Study of Pulmonary Hypertension in Sickle Cell Disease
Florence Parent et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Population Estimates of Sickle Cell Disease in the US
Kathryn L. Hassell
AMERICAN JOURNAL OF PREVENTIVE MEDICINE (2010)
Exercise capacity and haemodynamics in patients with sickle cell disease with pulmonary hypertension treated with bosentan: results of the ASSET studies
Robyn J. Barst et al.
BRITISH JOURNAL OF HAEMATOLOGY (2010)
Updated Clinical Classification of Pulmonary Hypertension
Gerald Simonneau et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2009)
Deconstructing sickle cell disease: Reappraisal of the role of hemolysis in the development of clinical subphenotypes
Gregory J. Kato et al.
BLOOD REVIEWS (2007)
Sildenafil therapy in patients with sickle cell disease and pulmonary hypertension
RF Machado et al.
BRITISH JOURNAL OF HAEMATOLOGY (2005)
Pulmonary hypertension as a risk factor for death in patients with sickle cell disease
MT Gladwin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Share Paper
